The RfxCas13d system has also been used in silencing targeted mRNA to improve outcomes in the nervous system [36] (SOD1 and HTT in a model of amyotrophic lateral sclerosis and Huntington’s disease, respectively). The gene discussed is SOD1; the disease is Huntington disease.